skip to main content
Idioma:
Refinado por: Nome da Publicação: Journal Of The Neurological Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Opicapone odds ratio in relative off-time reduction: A post-hoc analysis from combined BIPARK-I and II data
Opicapone odds ratio in relative off-time reduction: A post-hoc analysis from combined BIPARK-I and II data
Material Type:
Artigo 		Adicionar ao Meu Espaço

Opicapone odds ratio in relative off-time reduction: A post-hoc analysis from combined BIPARK-I and II data

Rocha, F. ; Poewe, W. ; Rascol, O. ; Lees, A. ; Ferreira, J. ; Santos, A. ; Magalhaes, D. ; Soares-da-Silva, P.

Journal of the neurological sciences, 2019-10, Vol.405, p.87-88 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
2
Switching entacapone ‘non-responders’ to open-label opicapone: Change in absolute off-time following the 1-year extension BIPARK-I study
Switching entacapone ‘non-responders’ to open-label opicapone: Change in absolute off-time following the 1-year extension BIPARK-I study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Switching entacapone ‘non-responders’ to open-label opicapone: Change in absolute off-time following the 1-year extension BIPARK-I study

Ferreira, J. ; Lees, A. ; Poewe, W. ; Rascol, O. ; Santos, A. ; Magalhaes, D. ; Rocha, F. ; Soares-da-Silva, P.

Journal of the neurological sciences, 2019-10, Vol.405, p.217-218 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
3
Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline mao-b inhibitors use: Post-hoc analysis from double-blind combined BIPARK-I and II data
Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline mao-b inhibitors use: Post-hoc analysis from double-blind combined BIPARK-I and II data
Material Type:
Artigo 		Adicionar ao Meu Espaço

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline mao-b inhibitors use: Post-hoc analysis from double-blind combined BIPARK-I and II data

Costa, R. ; Ferreira, J. ; Lees, A. ; Tolosa, E. ; Poewe, W. ; Gama, H. ; Magalhaes, D. ; Rocha, F. ; Soares-da-Silva, P.

Journal of the neurological sciences, 2019-10, Vol.405, p.202-202 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
4
Efficacy of opicapone in Parkinson’s disease patients according to baseline rasagiline use: A post-hoc analysis from combined BIPARK-I and II
Efficacy of opicapone in Parkinson’s disease patients according to baseline rasagiline use: A post-hoc analysis from combined BIPARK-I and II
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy of opicapone in Parkinson’s disease patients according to baseline rasagiline use: A post-hoc analysis from combined BIPARK-I and II

Lees, A. ; Ferreira, J. ; Rascol, O. ; Poewe, W. ; Tolosa, E. ; Gama, H. ; Magalhaes, D. ; Rocha, F. ; Soares-da-Silva, P.

Journal of the neurological sciences, 2019-10, Vol.405, p.193-193 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
5
Effect of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Parkinson’s disease questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience
Effect of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Parkinson’s disease questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Parkinson’s disease questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience

Rocha, F. ; Tolosa, E. ; Ferreira, J. ; Rascol, O. ; Poewe, W. ; Santos, A. ; Magalhaes, D. ; Soares-da-Silva, P.

Journal of the neurological sciences, 2019-10, Vol.405, p.190-191 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
6
Efficacy of opicapone in Parkinson’s disease patients according to baseline pramipexole use: A post-hoc analysis from combined BIPARK-I and II
Efficacy of opicapone in Parkinson’s disease patients according to baseline pramipexole use: A post-hoc analysis from combined BIPARK-I and II
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy of opicapone in Parkinson’s disease patients according to baseline pramipexole use: A post-hoc analysis from combined BIPARK-I and II

Lees, A. ; Ferreira, J. ; Rascol, O. ; Poewe, W. ; Stocchi, F. ; Santos, A. ; Magalhaes, D. ; Rocha, F. ; Soares-da-Silva, P.

Journal of the neurological sciences, 2019-10, Vol.405, p.192-193 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
7
Incidence of treatment-emergent adverse events in Parkinson's disease patients according to gender: Post-hoc analysis from double-blind combined BIPARK-I and II data
Incidence of treatment-emergent adverse events in Parkinson's disease patients according to gender: Post-hoc analysis from double-blind combined BIPARK-I and II data
Material Type:
Artigo 		Adicionar ao Meu Espaço

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to gender: Post-hoc analysis from double-blind combined BIPARK-I and II data

Costa, R. ; Ferreira, J. ; Lees, A. ; Tolosa, E. ; Poewe, W. ; Ikedo, F. ; Magalhaes, D. ; Rocha, F. ; Soares-da-Silva, P.

Journal of the neurological sciences, 2019-10, Vol.405, p.201-201 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
8
Incidence of treatment-emergent adverse events in Parkinson's Disease patients according to baseline body mass index: Post-hoc analysis from double-blind combined BIPARK-I and II data
Incidence of treatment-emergent adverse events in Parkinson's Disease patients according to baseline body mass index: Post-hoc analysis from double-blind combined BIPARK-I and II data
Material Type:
Artigo 		Adicionar ao Meu Espaço

Incidence of treatment-emergent adverse events in Parkinson's Disease patients according to baseline body mass index: Post-hoc analysis from double-blind combined BIPARK-I and II data

Costa, R. ; Ferreira, J. ; Lees, A. ; Tolosa, E. ; Poewe, W. ; Ikedo, F. ; Diogo, M. ; Rocha, F. ; Soares-da-Silva, P.

Journal of the neurological sciences, 2019-10, Vol.405, p.200-200 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
9
Switching from double-blind entacapone or placebo to open-label opicapone: change in OFF-/ON-time from patients who ended the 1-year BIPARK-I extension on opicapone 50 mg
Switching from double-blind entacapone or placebo to open-label opicapone: change in OFF-/ON-time from patients who ended the 1-year BIPARK-I extension on opicapone 50 mg
Material Type:
Artigo 		Adicionar ao Meu Espaço

Switching from double-blind entacapone or placebo to open-label opicapone: change in OFF-/ON-time from patients who ended the 1-year BIPARK-I extension on opicapone 50 mg

Ferreira, J. ; Lees, A. ; Rascol, O. ; Poewe, W. ; Ikedo, F. ; Magalhaes, D. ; Rocha, F. ; Soares-da-Silva, P.

Journal of the neurological sciences, 2019-10, Vol.405, p.218-218 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por
10
Opicapone as a levodopa sparing agent: Pooled analysis of BIPARK-I and II double-blind trials
Opicapone as a levodopa sparing agent: Pooled analysis of BIPARK-I and II double-blind trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Opicapone as a levodopa sparing agent: Pooled analysis of BIPARK-I and II double-blind trials

Hauser, R. ; Rascol, O. ; Poewe, W. ; Ferreira, J. ; Lees, A. ; Klepitskaya, O. ; Liang, G. ; Santos, A. ; Magalhaes, D. ; Rocha, F. ; Soares-da-Silva, P.

Journal of the neurological sciences, 2019-10, Vol.405, p.218-219 [Periódico revisado por pares]

Elsevier B.V

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Data de Publicação 

De até
Refinar

Base de Dados/Biblioteca 

  1. ScienceDirect®  (15)
  2. ClinicalKey  (15)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.